FDA Warns of Stroke, Death With Off-Label Use of Wingspan Stent

A post market surveillance study has found a significantly higher incidence of stroke or death when the Wingspan Stent System (Stryker) is used outside the US Food and  Drug Administration (FDA) approved indications, the agency has warned in a safety communication today.